Orthofix Medical Inc. Common Stock (DE) (OFIX) — Analysis Summary
Orthofix Medical Inc. Common Stock (DE) (OFIX) has a market cap of $476.57M with year-over-year revenue growth of +2.9%. Net margin stands at -11.2%. The stock trades at a P/E ratio of -7.9.
Key Takeaways
- Revenue changed +2.9% year-over-year
- Net margin of -11.2%
- P/E ratio of -7.9
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, OFIX posted revenue growth of +2.9% and trades at a P/E of -7.9.
Orthofix Medical Inc. Common Stock (DE) (OFIX)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Debt/EBITDA at 23.6x — highly leveraged, potential refinancing risk
Interest coverage at -2.5x — earnings do not cover interest payments
The latest filing shows negative free cash flow.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
1,605
Headquarters
LEWISVILLE, TX
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.